Related Experiment Video
Updated: Feb 9, 2026

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
Published on: March 10, 2015
Artificial strain of human prions created in vitro
Chae Kim1, Xiangzhu Xiao2, Shugui Chen2,3
1Department of Pathology, Case Western Reserve University, 2085 Adelbert Rd, Cleveland, OH, 44106, USA.
Abstract:
The molecular mechanism that determines under physiological conditions transmissibility of the most common human prion disease, sporadic Creutzfeldt-Jakob disease (sCJD) is unknown. We report the synthesis of new human prion from the recombinant human prion protein expressed in bacteria in reaction seeded with sCJD MM1 prions and cofactor, ganglioside GM1. These synthetic human prions were infectious to transgenic mice expressing non-glycosylated human prion protein, causing neurologic dysfunction after 459 and 224 days in the first and second passage, respectively. The neuropathology, replication potency, and biophysical profiling suggest that a novel, particularly neurotoxic human prion strain was created. Distinct biological and structural characteristics of our synthetic human prions suggest that subtle changes in the structural organization of critical domains, some linked to posttranslational modifications of the pathogenic prion protein (PrPSc), play a crucial role as a determinant of human prion infectivity, host range, and targetting of specific brain structures in mice models.
Insights
Researchers synthesized infectious human prions from recombinant prion protein. These prions caused neurological disease in mice, suggesting structural changes in prion protein influence infectivity and disease characteristics.
Area of Science:
- Neuroscience
- Biochemistry
- Infectious Diseases
Background:
- Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common human prion disease.
- The molecular mechanisms governing sCJD transmissibility remain largely unknown.
- Understanding prion infectivity is crucial for developing therapeutic strategies.
Purpose of the Study:
- To synthesize infectious human prions from recombinant human prion protein.
- To investigate the biological and structural characteristics of these synthetic prions.
- To explore the role of structural modifications in prion infectivity and host targeting.
Main Methods:
- Recombinant human prion protein expressed in bacteria was used.
- Synthesis was seeded with sCJD MM1 prions and the cofactor ganglioside GM1.
- Infectivity was tested in transgenic mice expressing non-glycosylated human prion protein.
Main Results:
- Synthetic human prions were successfully created and were infectious to transgenic mice.
- Mice exhibited neurological dysfunction after 459 days (first passage) and 224 days (second passage).
- Neuropathology and biophysical profiling indicated a novel, neurotoxic human prion strain.
Conclusions:
- Subtle structural changes in prion protein domains, potentially including posttranslational modifications, are critical determinants of prion infectivity.
- These structural variations influence prion host range and specific brain structure targeting.
- The study provides insights into the molecular mechanisms of human prion disease transmission and pathogenesis.
Related Concept Videos
Natural and Artificial Concepts
Thermal Strain
Shearing Strain
Measurements of Strain
Strain Energy
Consider a rod that is fixed at one end and subjected to an axial force at the free end. This axial force induces stress within the rod, leading to its elongation. As the axial force increases, so does the elongation of the rod, illustrating a direct relationship between the force applied and the resulting...
Problem Solving on Stress and Strain

